Gifu Heart Center
6
0
1
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 6 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (6)
Influence of FFR on the Clinical Outcome After Percutaneous Coronary Intervention
Role: collaborator
Japan FFRangio Clinical Outcomes Study
Role: collaborator
Exploring the Mechanism of Plaque Rupture in Acute Coronary Syndrome Using Coronary CT Angiography and Computational Fluid Dynamics II (EMERALD II) Study
Role: collaborator
Inclusive Invasive Physiological Assessment in Angina Syndromes Registry
Role: collaborator
International Post PCI FFR Registry
Role: collaborator
Clinical Implication of 3-vessel Fractional Flow Reserve (FFR)
Role: collaborator
All 6 trials loaded